Information and Providers for Portrait Plasma PSR - Portrait PSR offers new treatment options for skin resurfacing with minimal downtime and benefits that have surpassed any other technology available today. Treatment with Portrait Plasma Skin Rejuvenation in extensive clinical trials show results which improve for up to one year after treatment.
Innovative use of existing PSR technology puts this device back in the facial rejuvenation game with results comparable to ablative resurfacing lasers but without their harsh healing cycle.
Unlike many other energies used to tighten skin and fix wrinkles, the Portrait Plasma Skin Regeneration uses the body's own skin to dress the "wounding" created by stimulating new collagen.
EndyMed Pro, the new fractional resurfacing technology from Eclipse Medical, may treat all skin colors effectively and safely with deeper radiofrequency (RF) energy.
The recent acquisition of Portrait Plasma Skin Rejuvenation by the Energist Group will provide previous Rhytec Portrait owners with new tips for their devices.
Although there are several treatments that claim to diminish acne scars, Rhytec, Inc.'s Portrait PSR3 Plasma system offers less downtime than fractional lasers on the market and was recently approved by the U.S. Food and Drug Administration (FDA) for use in treating acne scars
For many acne patients, the resulting acne scars which last long after the pimples have disappeared can cause considerable psychosocial distress. Now, a new study recently published in "Lasers in Surgery and Medicine" (August 2008 issue), the peer-reviewed professional journal of the American Society for Laser Medicine and Surgery, shows that a novel laser device combining CO2 ablation with the principles of fractional photothermolysis can significantly improve the appearance of acne scarring without compromising patient safety.
Tuesday, June 17, 2008 8:00pm EDT
Rhytec, Inc. the pioneer of plasma skin regeneration and sole provider of an aesthetic device which uses a novel thermal energy called plasma for reversing the signs of aging, announced it has received U.S. Food and Drug Administration (FDA) clearance to market a new indication for treating acne scars.